Keyphrases
Eradication Therapy
100%
Helicobacter Pylori Eradication
100%
Clinical Practice Guidelines
100%
Helicobacter Pylori Infection
50%
Bismuth Quadruple Therapy
50%
Pharmacological Treatment
50%
Stakeholder Preferences
25%
Clinical Recommendations
25%
Antibiotic Resistance Pattern
25%
Initial Treatment
25%
High-dose Dual Therapy
25%
Stakeholder Value
25%
Gastritis
25%
Rescue Treatment
25%
Practice Guidelines
25%
Evidence to Decision Framework
25%
Minimizing Bias
25%
Indigestion
25%
Peptic Ulcer
25%
Assessment Development
25%
Evaluation Assessment
25%
Developed Countries
25%
Low-middle Income Countries
25%
Public Health Burden
25%
Reporting Item
25%
World Health Organization
25%
Developing Countries
25%
Gastric Cancer
25%
Resource Use
25%
Prevalence Rate
25%
Antibiotic Resistance
25%
Control Disease
25%
Helicobacter Pylori (H. pylori)
25%
China
25%
Infectious Diseases
25%
Disease Progression
25%
Resource-limited Settings
25%
Healthcare
25%
Grading of Recommendations
25%
Guidelines International Network
25%
Bismuth
25%
Clinical Practice Guideline Development
25%
Medicine and Dentistry
Helicobacter Pylori
100%
Helicobacter Infection
40%
Antibiotic Resistance
40%
Prevalence
40%
Drug Therapy
40%
Jejunum Ulcer
20%
Empirical Treatment
20%
Dyspepsia
20%
Stomach Cancer
20%
Gastritis
20%
Low and Middle Income Countries
20%
Infection
20%
Emergency Medical Technician
20%
Drug Megadose
20%
Disease Exacerbation
20%
Public Health
20%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
100%
Helicobacter Infection
40%
Antibiotic Resistance
40%
Prevalence
40%
Indigestion
20%
Gastritis
20%
Jejunum Ulcer
20%
Stomach Cancer
20%
Disease Exacerbation
20%
Infection
20%